top of page


LambdaVision is Helping Patients Regain Sight by Developing the First Protein-Based Artificial Retina
LambdaVision , developer of protein-based artificial retinas, led by Nicole L. Wagner, Jordan A. Greco, and Robert R. Birge, has secured $7 million seed funding round co-led by Seven Seven Six and Aurelia Foundry Fund , with additional support from Seraphim Space , providing runway into 2027. Millions worldwide lose their vision each year to retinal diseases such as retinitis pigmentosa (RP) and age-related macular degeneration (AMD), with limited treatment options. The new
Menlo Times
3 days ago2 min read


Swedish-Based Cellcolabs is Making Stem Cell Therapies Mainstream
Cellcolabs , manufacturing High-Quality Mesenchymal Stromal Cells, led by Petter Hallman, Mattias Bernow, Lina Sörvik, Heidi Stensmyren, and others, has raised $12 million in a round led by Titian Capital. Global demand for regenerative therapies is surging, yet high costs and limited production still restrict access for many patients. Stockholm-based Cellcolabs, founded in 2021 by Dr. Mattias Bernow, aims to change this through industrial-scale stem cell manufacturing. Its
Menlo Times
Oct 281 min read


Adaptam Therapeutics Secures €3M to Redefine Cancer Immunotherapy by Targeting the Body’s Hidden Suppressors
Adaptam Therapeutics , a pioneering company in cancer immunotherapies specifically targeting the immunosuppressive myeloid tumor microenvironment, led by Asis Palazon, Pablo Cironi, Salvatore Cappadona, and José M. Mato, has secured a €3 million (~$3.5 million) pre-seed financing round led by Criteria Bio Ventures . As part of the round, Criteria Bio Ventures’ Salvatore Cappadona, PhD, and Pablo Cironi, PhD, join Adaptam’s board of directors. The €3M funding will advance Ada
Menlo Times
Oct 281 min read


Deepinder Goyal Announces a $25 Million Fund backed by Personal Investment Supporting Research in Aging Biology, Evolution, and Longevity
Continue Research , a 2-year-old research effort to identify and study upstream mechanisms in biology, started by Deepinder Goyal, has announced a $25 million fund to back researchers, funded by personal investment, and is not a part of Eternal. The next breakthroughs in aging biology are hiding in plain sight, emerging not from added complexity but from uncovering foundational mechanisms that control everything downstream. A $25M fund supports researchers testing ideas so si
Menlo Times
Oct 241 min read


How NewLimit Plans to Extend Human Healthspan using Epigenetic Reprogramming
NewLimit , a biotechnology company focused on human longevity, led by Blake Byers, Brian Armstrong, Cathy O'Hare, and Jacob Kimmel, has secured an additional $45 million from Eli Lilly and Company, Duke Management Co., Section 32, and others, bringing its market capitalization to $1.62 billion. Insiders, including Kleiner Perkins, Dimension, Abstract, Human Capital, and Boost, also participated. Significant progress has been made in developing medicines that rejuvenate aging
Menlo Times
Oct 221 min read


Tubulis Raises €308 Million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline
Tubulis , reimagining antibody drug conjugates, led by Dr. Dominik Schumacher, Dr. Jonas Helma-Smets, Dr. Ingo Lehrke, Dr. Günter Fingerle-Rowson, MD, Dr. Björn Hock, Dr. Matthew Norkunas, and others, has secured €308 million (USD 361 million) financing. The round was led by Venrock Healthcare Capital Partners with participation from additional new investors Wellington Management and Ascenta Capital . Existing investors who supported the Series C include Nextech Invest , E
Menlo Times
Oct 162 min read


Nabla Bio Signs Second Takeda Collaboration to Advance AI-Driven Design of Protein Therapeutics
Nabla Bio , making drug development designable with generative AI, led by Surge Biswas, Frances Anastassacos, Rose Harrison, and others, announced a new, multi-year research collaboration with Takeda. Under the agreement, Nabla Bio will receive double-digit millions in upfront and research payments, with potential success-based payments exceeding $1 billion. The collaboration will deploy Nabla Bio’s Joint Atomic Model (JAM) platform across Takeda’s early-stage programs, incl
Menlo Times
Oct 151 min read


How Phagos is Using AI to End Bacterial Disease
Phagos , the sustainable alternative to antibiotics, led by Alexandros Pantalis and Adèle James , has secured 25 million euros Series A...
Menlo Times
Oct 82 min read


Trogenix Advances Clinical Development of Potentially Curative Therapies for Aggressive Cancers
Trogenix Ltd (“Trogenix”), a pioneering biotech company dedicated to developing innovative cancer therapies, led by Prof. Steve Pollard,...
Menlo Times
Oct 71 min read


Until Labs Closes $58 Million in Series A
Until Labs , the company developing reversible cryopreservation for patients in need of donor organs, led by Hunter Davis and Laura...
Menlo Times
Sep 231 min read


DaltonTx Raises £4 Million Seed Financing to Build the Intelligence Backbone of Drug Discovery
DaltonTx , a collaborative intelligence platform redefining how technology powers drug discovery, led by Dr. Garry Pairaudeau, Dr....
Menlo Times
Sep 231 min read


Conceivable Life Sciences Raises $50 Million For AI Automation And Robotic Precision in IVF
Conceivable Life Sciences , the World’s First AI-Powered Automated IVF Lab, led by Joshua Abram, Alan Murray, Alejandro Chavez-Badiola,...
Menlo Times
Sep 171 min read


Genoskin Raises $8.7 Million Series A to Support Drug Development with Ethical, Human-Based Models
Genoskin , bringing unparalleled expertise in skin biology and immunology to advance research and drug development efforts led by Pascal...
Menlo Times
Sep 162 min read


BoobyBiome Raises £2.5 Million to Protect Breast Milk’s Microbiome and Transform Infant Health
BoobyBiome , a startup spun out of University College London’s Great Ormond Street Institute of Child Health, led by Dr Lydia Mapstone,...
Menlo Times
Sep 91 min read


Integra Therapeutics secures €10.7 Million Investment Round to Advance Development of FiCAT Gene Writing Platform and Preclinical Validation of CAR-T Therapies
Integra Therapeutics , a global leader in cutting-edge gene writing tools to improve the efficacy, led by Avencia Sánchez-Mejíasa and...
Menlo Times
Sep 81 min read


NRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing to Deliver Clinical Data in Parkinson’s and Proof of Concept in ALS/MND
NRG Therapeutics Ltd. (“NRG”) , an innovative neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, led...
Menlo Times
Sep 81 min read


MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline
MRM Health NV , a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and...
Menlo Times
Sep 51 min read


LIfT BioSciences Announces Grant of €12 Million to Support the First-in-Human Clinical Trial of LIfT’s IMAN Therapy
LIft BioSciences, a rapidly emerging biotech and the global leader in neutrophil immunotherapies, led by Alex Blyth(CEO and Founder),...
Menlo Times
Jul 291 min read


ÄIO Secures €1 Million Public Funding to Develop Fats and Oils for the Cosmetics Industries
AIO, an Estonian Biotechnology Company led by Nemailla Bonturi(Co-Founder and CEO), Petri-Jaan Lahtvee(Co-Founder and COO), Mary-Liis...
Menlo Times
Jul 231 min read


Nudge Secures $100 Million in Series A to Build Whole Brain Interfaces for Everyday Life
Led by Co-Founders Quintin Frerichs and Fred Ehrsam , Nudge raised $100 Million in Series A led by Thrive Capital and Greenoaks ....
Menlo Times
Jul 231 min read
bottom of page